Cite
HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use.
MLA
Rees, Helen, et al. “HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use.” JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 88, no. 4, Dec. 2021, pp. 376–83. EBSCOhost, https://doi.org/10.1097/QAI.0000000000002785.
APA
Rees, H., Chersich, M. F., Munthali, R. J., Brumskine, W., Palanee-Phillips, T., Nkala, B., Ahmed, K., Sebe, M., Mabude, Z., Nchabeleng, M., Bekker, L.-G., Kotze, P., Mogodiri, T., Naidoo, I., Panchia, R., Myer, L., Lombard, C., Doncel, G. F., Gray, G., & Delany-Moretlwe, S. (2021). HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 88(4), 376–383. https://doi.org/10.1097/QAI.0000000000002785
Chicago
Rees, Helen, Matthew Francis Chersich, Richard J. Munthali, William Brumskine, Thesla Palanee-Phillips, Busi Nkala, Khatija Ahmed, et al. 2021. “HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use.” JAIDS: Journal of Acquired Immune Deficiency Syndromes 88 (4): 376–83. doi:10.1097/QAI.0000000000002785.